DempoChem Logo
  1. HomeHome
  2. /ProductsProducts
  3. /Building BlocksBuilding Blocks
  4. /Heterocyclic ScaffoldsHeterocyclic Scaffolds
  5. /PiperazinesPiperazines
  6. /KRAS G12C inhibitor 68KRAS G12C inhibitor 68
Chemical structure of CAS 3034851-27-6

KRAS G12C inhibitor 68

CAS No.3034851-27-6
MDL No.N/A
MFC35H44F2N6O3
MW634.80
InChI KeyFMBHZLHLHLRGAZ-LARAJFFGSA-N
CUSTOM SYNTHESIS

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.3034851-27-6
Product NameKRAS G12C inhibitor 68
Heavy Atom Count46Rotatable Bond Count7
Atom Stereo Count4Bond Stereo Count0
HBA8HBD0
TPSA74.270 ŲCharge0
Exact Mass634.34430Complexity1516.38
pKa9.613XLogP4.671

Documentation

Similar Products

  • Aspidospermidine-3-carboxylic acid, 4-(acetyloxy)-6,7-didehydro-15-((2R,4R,6S,8S)-4-(1,1-difluoroethyl)-1,3,4,5,6,7,8,9-octahydro-8-(methoxycarbonyl)-2,6-methano-2H-azecino(4,3-b)indol-8-yl)-3-hydroxy-16-methoxy-1-methyl-, methyl ester, (2beta,3beta,4beta,5alpha,12R,19alpha)-

    CAS No.162652-95-1

  • Vinflunine Ditartrate

    CAS No.194468-36-5

  • Ecubectedin

    CAS No.2248127-53-7

  • Vinblastine

    CAS No.865-21-4

  • Vinblastine Sulfate

    CAS No.143-67-9

  • (+)-Vincristine

    CAS No.132142-73-5

Your Partner for
Complex Chemistry
logo
  • About Us
  • Perspectives
  • Products
  • Contact
  • Preclinical Development
  • Technologies
  • Custom Synthesis
Ready to start your project?

Provide your target molecule or project specifications to align on a tailored development and scale-up pathway with our scientific team.

START A PROJECT
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
Westerstraat 10, 3016 DH, Rotterdam, The Netherlands
logo

All products are supplied strictly for research and development use only and are not intended for human or veterinary administration, diagnostic use, or therapeutic use. Preclinical and related services are provided solely for research and development purposes and do not constitute clinical diagnosis, treatment, or veterinary care.

©2026 DempoChem. All Rights Reserved.
DHLFedExUPSPostNL
CLIENT PORTAL|TERMS AND CONDITIONS|PRIVACY POLICY|
  • Products
    • CDMO Compounds
    • API & Candidates
  • Services
    CDMO & Manufacturing
    • Custom Synthesis
    • Process Development
    • Lab To Pilot
    • Commercialization
    • Generic APIs
    CRO
    • Preclinical
    • Pharmacology & Efficacy
    • DMPK & Bioanalysis
    • Toxicology & Safety
    • Disease Models
    Technologies
    • High-Potent
    • Chiral Synthesis
    • Cloud Synthesis
    • Fermentation
    • Flow Chemistry
    • Biocatalysis
    Support
    • Regulatory Support
    • Supply Chain Solutions
  • About
  • Perspectives
  • Contact